移植物抗宿主病
医学
造血干细胞移植
发病机制
重症监护医学
疾病
慢性病
免疫学
移植
干细胞
造血细胞
造血
生物信息学
内科学
生物
遗传学
标识
DOI:10.1016/j.beha.2021.101253
摘要
Chronic graft-versus-host disease (cGVHD) is a major cause of poor outcomes after hematopoietic stem cell transplantation (HCT). An increased understanding of the pathobiology of cGVHD has led to the development of novel therapies. This review summarized the underlying pathogenesis of cGVHD and has provided considerations for integrating new agents into practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI